Publications
Group highlights
At the end of this page, you can find the full list of publications.
Here we show that completely abolishing β-arrestin recruitment improves the anti-hyperglycaemic effects of GLP-1R agonists in mice.
Hinds CE, Peace E, Chen S, Davies I, El Eid L, Tomas A, Tan T, Minnion J, Jones B, Bloom SR
Diabetes, Obesity and Metabolism a journal of pharmacology and therapeutics, Vol: 26, Pages: 65-77
We discovered 120 RG loci represented by 150 distinct signals, including 13 with sex-dimorphic effects, two cross-ancestry and seven rare frequency signals
Lagou V, Jiang L, Ulrich A, et al.
Nature Genetics, Vol: 55, Pages: 1448-1461
Here, we have assessed in vivo glycemic responses to the pharmacological GLP-1R agonist exendin-4 in adult β cell-specific β-arrestin 2 knockout (KO) mice
Tomas Catala A, Bitsi S, Manchanda Y, El Eid L, Oqua A, Mohamed N, Hansen B, Suba K, Rutter G, Jones B, Salem V
Science Advances, Vol: 9, Pages: 1-23, 2023
C-terminal acylation of biased GLP-1R agonists increases their degree of signal bias in favour of cAMP production and improves their therapeutic potential
Jones B, Pickford P, Lucey M, Tomas-Catala A, Minnion J, Bitsi S, Ungewiss J, Schoeneberg K, Rutter G, Bloom S
Molecular Metabolism, Vol: 37, 2020
In the present study, we demonstrate an important role for the translocation of active GLP-1Rs into liquid-ordered plasma membrane nanodomains, which act as hotspots for optimal coordination of intracellular signaling and clathrin-mediated endocytosis. This process is dynamically regulated by agonist binding through palmitoylation of the GLP-1R at its carboxyl-terminal tail
Buenaventura T, Bitsi S, Laughlin WE, Burgoyne T, Lyu Z, Oqua AI, Norman H, McGlone ER, Klymchenko AS, Corrêa IR, Walker A, Inoue A, Hanyaloglu A, Grimes J, Koszegi Z, Calebiro D, Rutter GA, Bloom SR, Jones B, Tomas A
PLoS Biology, Vol: 17, Pages: 1-40, 2019
Here, we investigate a series of biased GLP-1R agonists with variable propensities for GLP-1R internalization and recycling. Compared to a panel of FDA-approved GLP-1 mimetics, compounds that retain GLP-1R at the plasma membrane produce greater long-term insulin release, which is dependent on a reduction in β-arrestin recruitment and faster agonist dissociation rates
Jones B, Buenaventura T, Kanda N, Chabosseau P, Owen B, Scott R, Goldin R, Angkathunyakul N, Correa Jr IR, Bosco D, Johnson PR, Piemonti L, Marchetti P, Shapiro AMJ, Cochran B, Hanyaloglu A, Inoue A, Tan T, Rutter G, Tomas Catala A, Bloom S
Nature Communications, Vol: 9, 2018
Full list of publications
Chronic GIPR agonism results in pancreatic islet GIPR functional desensitisation
Davies I, Adrieanssens A, Scott W, Carling D, Murphy K, Minnion J, Bloom S, Jones B, Tan T
Molecular Metabolism - Volume 92, February 2025
The physiological impact of an N-terminal Halo-tag on glucose-dependent insulinotropic polypeptide receptor function in mice
Davies I, Manchanda Y, Sloop K, Bloom S, Tan T, Tomas A, Jones B
Diabetes, Obesity and Metabolism - Volume 27, February 2025
Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand effects in pancreatic β-cells and neurons
Bridge, L and Chen, S and Jones, B
Cellular Signalling - Volume 119, July 2024
Abolishing β-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonists
Hinds CE, Peace E, Chen S, Davies I, El Eid L, Tomas A, Tan T, Minnion J, Jones B, Bloom SR
Diabetes, Obesity and Metabolism a journal of pharmacology and therapeutics, Vol: 26, Pages: 65-77
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification
Lagou V, Jiang L, Ulrich A, et al.
Nature Genetics, Vol: 55, Pages: 1448-1461
Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism
Xiao J, El Eid L, Buenaventura T, Boutry R, Bonnefond A, Jones B, Rutter GA, Froguel P, Tomas A
Diabetes, Obesity and Metabolism, Vol: 25, Pages: 2105-2119, 2023
Hypothalamic and brainstem glucose- dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding
Adriaenssens A, Broichhagen J, de Bray A, Ast J, Hasib A, Jones B, Tomas A, Burgos NF, Woodward O, Lewis J, O’Flaherty E, Kimberley E, Cui C, Harada N, Inagaki N, Campbell J, Brierley D, Hodson DJ, Samms R, Gribble F, Reimann F
JCI INSIGHT, Vol: 8, 2023
Enhanced endosomal signaling and desensitization of GLP-1R versus GIPR in pancreatic beta cells
Manchanda Y, Bitsi S, Chen S, Broichhagen J, Bernardino de la Serna J, Jones B, Tomas A
Endocrinology, Vol: 164, Pages: 1-15, 2023
Divergent acute versus prolonged pharmacological GLP-1R responses in adult beta cell-specific β-arrestin 2 knockout mice
Tomas Catala A, Bitsi S, Manchanda Y, El Eid L, Oqua A, Mohamed N, Hansen B, Suba K, Rutter G, Jones B, Salem V
Science Advances, Vol: 9, Pages: 1-23, 2023
The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia
Thayabaran D, Tsui APT, Ebmeier S, Cegla J, David A, Jones B
Journal of Clinical Lipidology, Vol: 17, Pages: 244-254, 2023
Lipid-lowering with inclisiran: areal-world single-centre experience
Padam P, Barton L, Wilson S, David A, Walji S, De Lorenzo F, Ray K, Jones B, Cegla J
Open Heart, Vol: 9, 2022
Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss
Hope D, Hinds C, Lopes T, Vincent M, Shrewsbury J, Yu A, Davies I, Scott R, Jones B, Murphy K, Minnion J, Sardini A, Carling D, Lutz T, Bloom S, Tan T, Owen B
Cell Reports Medicine, Vol: 3, 2022
Hepatocyte cholesterol content modulates glucagon receptor signalling
McGlone ER, Dunsterville C, Carling D, tomas A, Bloom S, Tan T, Jones B
Molecular Metabolism, Vol: 63, 2022
Sulfonated red and far-red rhodamines to visualize SNAP- and Halo-tagged cell surface proteins
Birke R, Ast J, Roosen DA, Lee J, Rossmann K, Huhn C, Mathes B, Lisurek M, Bushiri D, Sun H, Jones B, Lehmann M, Levitz J, Haucke V, Hodson DJ, Broichhagen J
ORGANIC & BIOMOLECULAR CHEMISTRY, Vol: 20, Pages: 5967-5980, 2022
Methyl deuterated rhodamines for protein labelling in sensitive fluorescence microscopy
Rossmann K, Akkaya KC, Poc P, Charbonnier C, Eichhorst J, Gonschior H, Valavalkar A, Wendler N, Cordes T, Dietzek-Ivansic B, Jones B, Lehmann M, Broichhagen J
CHEMICAL SCIENCE, Vol: 13, Pages: 8605-8617, 2022
In vivo and in vitro characterization of GL0034, a novel long-acting glucagon-like peptide-1 receptor agonist
Jones B, Burade V, Akalestou E, Manchanda Y, Ramchunder Z, Carrat G, Nguyen-Tu M-S, Marchetti P, Piemonti L, Leclerc I, Thennati R, Vilsboll T, Thorens B, Tomas A, Rutter GA
Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, Vol: 24, Pages: 2090-2101, 2022
Mitofusins Mfn1 and Mfn2 are required to preserve glucose- but not incretin-stimulated beta cell connectivity and insulin secretion
Georgiadou E, Muralidharan C, Martinez M, Chabosseau P, Akalestou E, Tomas A, Yong Su Wern F, Stylianides T, Wretlind A, Legido-Quigley C, Jones B, Lopez Noriega L, Xu Y, Gu G, Alsabeeh N, Cruciani-Guglielmacci C, Magnan C, Ibberson M, Leclerc I, Ali Y, Soleimanpour SA, Linnemann AK, Rodriguez TA, Rutter GA
Diabetes, Vol: 71, Pages: 1472-1489, 2022
The therapeutic potential of GLP-1 receptor biased agonism
Jones B
British Journal of Pharmacology, Vol: 179, Pages: 492-510, 2022
The metabolomic effects of tripeptide gut hormone infusion compared to Roux-en-Y gastric bypass and caloric restriction
Jones B, Sands C, Alexiadou K, Minnion J, Tharakan G, Behary P, Ahmed A, Purkayastha S, Lewis M, Bloom S, Li J, Tan T
Journal of Clinical Endocrinology and Metabolism, Vol: 107, Pages: e767-e782, 2022
A glucagon analogue decreases body weight in mice via signalling in the liver.
Hinds CE, Owen BM, Hope DCD, Pickford P, Jones B, Tan TM, Minnion JS, Bloom SR
Scientific Reports, Vol: 11, Pages: 1-17, 2021
Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling
McGlone ER, Manchanda Y, Jones B, Pickford P, Inoue A, Carling D, Bloom S, Tan T, Tomas A
Molecular Metabolism, Vol: 53, Pages: 1-11, 2021
Acylation of the incretin peptide exendin-4 directly impacts GLP-1 receptor signalling and trafficking
Lucey M, Ashik T, Marzook A, Wang Y, Goulding J, Oishi A, Broichhagen J, Hodson D, Minnion J, Elani Y, Jockers R, Briddon S, Bloom S, Tomas A, Jones B
Molecular Pharmacology, Vol: 100, Pages: 319-334, 2021
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
Pickford P, Lucey M, Rujan R-M, McGlone ER, Bitsi S, Ashford FB, Corrêa IR, Hodson DJ, Tomas A, Deganutti G, Reynolds CA, Owen BM, Tan TM, Minnion J, Jones B, Bloom SR.
Molecular Metabolism, Vol: 51, 2021
Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1
Marzook A, Chen S, Pickford P, Lucey M, Wang Y, Corrêa Jr IR, Broichhagen J, Hodson DJ, Salem V, Rutter GA, Tan TM, Bloom SR, Tomas A, Jones B
Biochemical Pharmacology, Vol: 190, Pages: 1-12, 2021
An expanded LUXendin color palette for GLP1R detection and visualization in vitro and in vivo
Ast J, Novak AN, Podewin T, Fine NHF, Jones B, Tomas Catala A, Birke R, Roßmann K, Mathes B, Eichhorst J, Lehmann M, Linnemann AK, Hodson DJ, Broichhagen J
ChemRxiv, 2021
The interplay of glucagon-like peptide-1 receptor trafficking and signalling in pancreatic beta cells
Marzook A, Tomas A, Jones B
Frontiers in Endocrinology, Vol: 12, Pages: 1-12, 2021
GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo
Arcones AC, Vila-Bedmar R, Mirasierra M, Cruces-Sande M, Vallejo M, Jones B, Tomas A, Mayor F, Murga C
BMC Biology, Vol: 19, 2021
Spatiotemporal control of GLP-1 receptor activity
Manchanda Y, Bitsi S, Kang Y, Jones B, Tomas A
Endocrine and Metabolic Research, Vol: 16, Pages: 19-27, 2021
Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signalling at glucagon family receptors
Jones B, McGlone ER, Fang Z, Pickford P, Corrêa IR, Oishi A, Jockers R, Inoue A, Kumar S, Görlitz F, Dunsby C, French PMW, Rutter GA, Tan TM, Tomas A, Bloom SR
Journal of Biological Chemistry, Vol: 296, Pages: 1-15, 2021
Ligand-specific factors influencing GLP-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells
Jones B, Fang Z, Chen S, Manchanda Y, Bitsi S, Pickford P, David A, Shchepinova MM, Corrêa Jr IR, Hodson DJ, Broichhagen J, Tate EW, Reimann F, Salem V, Rutter GA, Tan T, Bloom SR, Tomas A
International Journal of Molecular Sciences, Vol: 212, Pages: 1-24, 2020
Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics.
Ast J, Arvaniti A, Fine NHF, Nasteska D, Ashford FB, Stamataki Z, Koszegi Z, Bacon A, Jones BJ, Lucey MA, Sasaki S, Brierley DI, Hastoy B, Tomas A, D’Agostino G, Reimann F, Lynn FC, Reissaus CA, Linnemann AK, D’Este E, Calebiro D, Trapp S, Johnsson K, Podewin T, Broichhagen J, Hodson DJ
Nature Communications, Vol: 11, 2020
CBD effects on TRPV1 signaling pathways in cultured DRG neurons
Anand U, Jones B, Korchev Y, Bloom S, Pacchetti B, Anand P, Sodergren M
Journal of Pain Research, Vol: 2020, Pages: 2269-2278
Signalling, trafficking and glucoregulatory properties of glucagon-like peptide-1 receptor agonists exendin-4 and lixisenatide
Pickford P, Lucey M, Fang Z, Bitsi S, Bernardino de la Serna J, Broichhagen J, Hodson DJ, Minnion J, Rutter GA, Bloom SR, Tomas A, Jones B
British Journal of Pharmacology, Vol: 177, Pages: 3905-3923, 2020
Interrogating surface versusintracellular transmembrane receptor populations using cell-impermeable SNAP-tag substrates
Poc P, Gutzeit VA, Ast J, Lee J, Jones BJ, D’Este E, Mathes B, Lehmann M, Hodson DJ, Levitz J, Broichhagen J
Vol: 11, Pages: 7871-7883, 2020
Disconnect between signalling potency and in vivo efficacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonists
Jones B, Pickford P, Lucey M, Tomas-Catala A, Minnion J, Bitsi S, Ungewiss J, Schoeneberg K, Rutter G, Bloom S
Molecular Metabolism, Vol: 37, 2020
Signal bias at glucagon family receptors: rationale and downstream impacts
Jones B, McGlone ER, Fang Z, Pickford P, Corrêa IR, Oishi A, Jockers R, Inoue A, Kumar S, Görlitz F, Dunsby C, French PMW, Rutter GA, Tan T, Tomas A, Bloom SR
bioRxiv, 2020
Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release
Ma Y, Ratnasabapathy R, De Backer I, Izzi-Engbeaya C, Nguyen-Tu M-S, Cuenco J, Jones B, John C, Lam B, Rutter G, Yeo G, Dhillo W, Gardiner J
JCI insight, Vol: 5, 2020
The influence of peptide context on signaling and trafficking of glucagon-like peptide-1 receptor biased agonists
Fang Z, Chen S, Pickford P, Broichhagen J, Hodson DJ, Corrêa IR, Kumar S, Görlitz F, Dunsby C, French PMW, Rutter GA, Tan T, Bloom SR, Tomas A, Jones B
ACS Pharmacology & Translational Science, Vol: 3, 2020
New insights into beta cell GLP-1 receptor and cAMP signaling
Tomas A, Jones B, Leech C
Journal of Molecular Biology, Vol: 432, Pages: 1347-1366, 2020
The effects of dyslipidaemia and cholesterol modulation on erythrocyte susceptibility to malaria parasite infection
Koch M, Cegla J, Jones B, Lu Y, Mallar Z, Blagborough A, Angrisano F, Baum J
Malaria Journal, Vol: 18, 2019
Ureidopeptide GLP-1 analogues with prolonged activity in vivo via signal bias and altered receptor trafficking
Fremaux J, Venin C, Mauran L, Zimmer R, Koensgen F, Rognan D, Bitsi S, Lucey MA, Jones B, Tomas A, Guichard G, Goudreau SR
Chemical Science, Vol: 42, Pages: 9872-9879, 2019
Differences in signalling, trafficking and glucoregulatory properties of glucagon-like peptide-1 receptor agonists exendin-4 and lixisenatide
Pickford P, Lucey M, Fang Z, Bitsi S, Broichhagen J, Hodson DJ, Minnion J, Rutter GA, Bloom SR, Tomas A, Jones B
bioRxiv, 2019
Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells
Buenaventura T, Bitsi S, Laughlin WE, Burgoyne T, Lyu Z, Oqua AI, Norman H, McGlone ER, Klymchenko AS, Corrêa IR, Walker A, Inoue A, Hanyaloglu A, Grimes J, Koszegi Z, Calebiro D, Rutter GA, Bloom SR, Jones B, Tomas A
PLoS Biology, Vol: 17, Pages: 1-40, 2019
Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register
Humphries SE, Cooper JA, Capps N, Durrington PN, Jones B, McDowell IFW, Soran H, Neil AHW
Atherosclerosis, Vol: 281, Pages: 207-212, 2019
Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor and its functional interaction with plasma membrane nanodomains in pancreatic beta cells
Buenaventura T, Laughlin WE, Bitsi S, Burgoyne T, Lyu Z, Oqua AI, Norman H, McGlone ER, Klymchenko AS, Corrêa IR, Walker A, Inoue A, Hanyaloglou A, Rutter GA, Bloom SR, Jones B, Tomas A
bioRxiv, 2018
PRO-ATHEROSCLEROTIC LOW-DENSITY NEUTROPHILS ARE PRESENT IN HYPERCHOLESTEROLEMIA
Cochran BJ, Pinheiro D, Prendecki M, Jones B, Cegla J, Lee V, Barter PJ, Murphy AJ, Rye K-A, Woollard KJ
International Symposium on Atherosclerosis (ISA), 2018
Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons
Anand U, Yiangou Y, Akbar A, Quick T, MacQuillan A, Fox M, Sinisi M, Korchev YE, Jones B, Bloom SR, Anand P
PLoS ONE, Vol: 13, 2018
Targeting GLP-1 receptor trafficking to improve agonist efficacy
Jones B, Buenaventura T, Kanda N, Chabosseau P, Owen B, Scott R, Goldin R, Angkathunyakul N, Correa Jr IR, Bosco D, Johnson PR, Piemonti L, Marchetti P, Shapiro AMJ, Cochran B, Hanyaloglu A, Inoue A, Tan T, Rutter G, Tomas Catala A, Bloom S
Nature Communications, Vol: 9, 2018
Control of insulin secretion by GLP-1
Jones B, Bloom S, Buenaventura T, Tomas Catala ADD, Rutter G
Peptides, Vol: 100, Pages: 75-84, 2018
Conditional and reversible activation of class A and B G protein-coupled receptors using tethered pharmacology
Podewin T, Ast J, Broichhagen J, Fine N, Nasteska D, Leippe P, Gailer M, Buenaventura T, Kanda N, Jones B, M’Kadmi C, Baneres J-L, Marie J, Tomas Catala A, Trauner D, Hoffmann-Röder A, Hodson D
ACS Central Science, Vol: 4, Pages: 166-179, 2018
A targeted RNAi screen identifies endocytic trafficking factors that control GLP-1 receptor signaling in pancreatic beta cells
Buenaventura T, Kanda N, Douzenis PC, Jones B, Bloom SR, Chabosseau P, Corrêa IR, Bosco D, Piemonti L, Marchetti P, Johnson PR, Shapiro AJ, Rutter GA, Tomas A
Diabetes, Vol: 67, Pages: 385-399, 2017
PCSK9 INHIBITION: REAL WORLD EXPERIENCE FROM THE HAMMERSMITH HOSPITAL LIPID CLINIC, LONDON
Cegla J, Walji S, Jones B, Scott J
85th Congress of the European-Atherosclerosis-Society (EAS), Publisher: ELSEVIER IRELAND LTD, Pages: E244-E245, 2017
RAMP2 influences glucagon receptor pharmacology via trafficking and signaling
Cegla J, Jones BJ, Gardiner JV, Hodson DJ, Marjot T, McGlone ER, Tan TM, Bloom SR
Endocrinology, Vol: 158, Pages: 2680-2693, 2017
Potent prearranged positive allosteric modulators of the glucagon-like peptide-1 receptor
Jones BJ, Scopelliti R, Tomas A, Bloom SR, Hodson DJ, Broichhagen J
ChemistryOpen, Vol: 6, Pages: 501-505, 2017
Development of a UHPLC-MS/MS (SRM) method for the quantitation of endogenous glucagon and dosed GLP-1 from human plasma
Howard JW, Kay RG, Jones B, Cegla J, Tan T, Bloom S, Creaser CS
BIOANALYSIS, Vol: 9, Pages: 733-751, 2017
The preanalytical stability of glucagon as measured by liquid chromatography tandem mass spectrometry and two commercially available immunoassays
Cegla J, Jones BJ, Howard J, Kay R, Creaser CS, Bloom SR, Tan TM
Annals of Clinical Biochemistry, Vol: 54, Pages: 293-296, 2017
Allosteric optical control of a class B G-protein-coupled receptor
Broichhagen J, Johnston NR, von Ohlen Y, Meyer-Berg H, Jones BJ, Bloom SR, Rutter GA, Trauner D, Hodson DJ
Angewandte Chemie - International Edition, Vol: 55, Pages: 5865-5868, 2016
Optical control of insulin secretion using an incretin switch
Broichhagen J, Podewin T, Meyer-Berg H, von Ohlen Y, Johnston NR, Jones BJ, Bloom SR, Rutter GA, Hoffmann-Röder A, Hodson DJ, Trauner D
Angewandte Chemie International Edition, Vol: 54, Pages: 15565-15569, 2015
The new era of drug therapy for obesity: The evidence and the expectations
Jones BJ, Bloom SR
Drugs, Vol: 75, Pages: 935-945, 2015
Glucagon-like peptide 1 deficiency in type 1 diabetes?
Jones B
ANNALS OF CLINICAL BIOCHEMISTRY, Vol: 52, Pages: 191-192, 2015
Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake
Cegla J, Troke RC, Jones B, Tharakan G, Kenkre J, McCullough KA, Lim CT, Parvizi N, Hussein M, Chambers ES, Minnion J, Cuenco J, Ghatei MA, Meeran K, Tan TM, Bloom SR
Diabetes, Vol: 63, Pages: 3711-3720, 2014
Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalism
Cegla J, Jones B, Seyani L, Papadoulou D, Wynne K, Martin NM, Meeran K, Chapman R, Donaldson M, Goldstone AP, Tan T
CLINICAL ENDOCRINOLOGY, Vol: 78, Pages: 738-742, 2013
In vitro fertilization treatment influences glucose tolerance in multiple pregnancy
Jones BJ, Zollner J, Haynes S, Cheng F, Dornhorst A
DIABETIC MEDICINE, Vol: 30, Pages: 252-254, 2013
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency
Fasano T, Zanoni P, Rabacchi C, Pisciotta L, Favari E, Adorni MP, Deegan PB, Park A, Hlaing T, Feher MD, Jones B, Uzak AS, Kardas F, Dardis A, Sechi A, Bembi B, Minuz P, Bertolini S, Bernini F, Calandra S
MOLECULAR GENETICS AND METABOLISM, Vol: 107, Pages: 534-541, 2012
Minireview: Glucagon in Stress and Energy Homeostasis
Jones BJ, Tan T, Bloom SR
ENDOCRINOLOGY, Vol: 153, Pages: 1049-1054, 2012
Comparison of reflective and reflex testing for hypomagnesaemia in severe hypokalaemia
Jones BJ, Twomey PJ
JOURNAL OF CLINICAL PATHOLOGY, Vol: 62, Pages: 816-819, 2009
Average serum triglyceride concentration in relation to day of the week in Burton-on-Trent
Jones BJ, Twomey PJ, Reynolds T
JOURNAL OF CLINICAL PATHOLOGY, Vol: 62, Pages: 671-672, 2009
Appropriateness of the National Academy of Clinical Biochemistry recommendation of repeating HbA1c analysis for extreme results in clinical practice
Yalamati P, Jones BJ, Twomey PJ
ANNALS OF CLINICAL BIOCHEMISTRY, Vol: 46, Pages: 165-166, 2009
Requesting patterns for serum calcium concentration in patients on long-term lithium therapy
Jones BJ, Twomey PJ
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, Vol: 63, Pages: 170-172, 2009
Effect of a manually generated laboratory comment on requesting and performance of valproate assays
Jones BJ, Twomey PJ
JOURNAL OF CLINICAL PATHOLOGY, Vol: 61, Pages: 1231-1231, 2008
Introduction of automatically generated comment in clinical biochemistry: an audit of technical effectiveness
Twomey PJ, Jones BJ, Pledger DR
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, Vol: 65, Pages: 102-103, 2008
Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes
Hejmadi MV, Dajas-Bailador F, Barns SM, Jones B, Wonnacott S
MOLECULAR AND CELLULAR NEUROSCIENCE, Vol: 24, Pages: 779-786, 2003